Christopher Lai

Vorstandsvorsitzender bei METIS TECHBIO CO., LTD.

Vermögen: 289 Mio $ am 30.06.2026

36 Jahre

Health Technology

Producer Manufacturing

Process Industries

Profil

Christopher Lai was the founder of AquaFresco, Inc., founded in 2015, and held the title of Chief Technology Officer.
Dr. Lai is the founder of Metis Pharmaceuticals, founded in 2019, and holds the titles of General Manager and Executive Director.
Dr. Lai is the founder of Metis TechBio Co., Ltd., founded in 2020, and holds the titles of Chairman and Chief Executive Officer.
Dr. Lai is also the founder of METiS Therapeutics, Inc...

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
METIS TECHBIO CO., LTD. CLASS H 10,26 %	10.06.2026	111.166.572 ( 10,26 % )	218 Mio $	30.06.2026
METIS TECHBIO CO., LTD. 36,55 %	13.05.2026	36.400.278 ( 36,55 % )	71 Mio $	30.06.2026

Aktive Positionen von Christopher Lai

Unternehmen	Position	Beginn
METIS TECHBIO CO., LTD.	Vorstandsvorsitzender	10.01.2020
METiS Therapeutics, Inc. METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases	Vorstandsvorsitzender	-
Metis Pharmaceuticals Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform	Gründer	01.01.2019

Alle aktiven Positionen von Christopher Lai

Ehemalige bekannte Positionen von Christopher Lai

Unternehmen	Position	Ende
AquaFresco, Inc. AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology	Gründer	-

Sehen Sie sich die Erfahrung von Christopher Lai im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Christopher Lai im Detail an

Unternehmensverbindungen

Private Unternehmen	4
AquaFresco, Inc. AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology	Producer Manufacturing
Metis Pharmaceuticals Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform	Health Technology
METiS Therapeutics, Inc. METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases	Health Technology
Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services	Process Industries